2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide
C24H28ClF2N7O2 — CID 155021421
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide
2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide (PubChem CID 155021421) has the molecular formula C24H28ClF2N7O2 and a molecular weight of 519.98 g/mol. Its IUPAC name is 2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide.
Molecular Properties
| Compound Name | 2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide |
|---|---|
| PubChem CID | 155021421 |
| Molecular Formula | C24H28ClF2N7O2 |
| Molecular Weight | 519.98 g/mol |
| Exact Mass | 519.20 |
| IUPAC Name | 2-[4-[8-(4-chloro-2,6-difluoroanilino)-2-[[(3S)-oxan-3-yl]amino]purin-9-yl]cyclohexyl]acetamide |
| SMILES | NC(=O)CC1CCC(n2c(Nc3c(F)cc(Cl)cc3F)nc3cnc(N[C@H]4CCCOC4)nc32)CC1 |
| InChI | InChI=1S/C24H28ClF2N7O2/c25-14-9-17(26)21(18(27)10-14)32-24-31-19-11-29-23(30-15-2-1-7-36-12-15)33-22(19)34(24)16-5-3-13(4-6-16)8-20(28)35/h9-11,13,15-16H,1-8,12H2,(H2,28,35)(H,31,32)(H,29,30,33)/t13?,15-,16?/m0/s1 |
| InChIKey | GAMAHOABRMLEGS-SIWZUTFBSA-N |
| XLogP | 4.70 |
| TPSA | 119.98 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 519.98 |
| LogP ≤ 5 | 4.70 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155021421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.